About
Cancer Diagnostics
Areas of Focus
Categories
DiagnosticsBoston & New England
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
1,823
By Phase
PHASE2: 1PHASE4: 1
By Status
COMPLETED: 6UNKNOWN: 3
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
Hover over trial bars to see details
Recent Trials
NCT03931369Collaborator
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
PHASE2Unknown
60 participants
Started: Sep 6, 2019 · Completed: Dec 30, 2020
NCT03130478Lead Sponsor
Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain
N/ACompleted
119 participants
Started: Jul 18, 2017 · Completed: Jul 30, 2018
NCT03130465Lead Sponsor
Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia
N/AUnknown
636 participants
Started: Jul 13, 2017 · Completed: Jan 31, 2020
NCT03005769Lead Sponsor
Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy
N/ACompleted
262 participants
Started: Dec 31, 2016 · Completed: Jul 31, 2017
NCT02848521Lead Sponsor
A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe
N/AUnknown
407 participants
Started: Oct 31, 2016 · Completed: Mar 31, 2020
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...